Q-Line Biotech
add_icon

Q-Line Biotech

474.60
+131.60
(38.37%)
Market Cap
1,107.16 Cr
PE Ratio
-
Volume
36,73,600.00
Day High - Low
474.60 - 431.00
52W High-Low
343.00 - 12.51
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
1,107.16 Cr
EPS
28.63
PE Ratio
-
PB Ratio
-
Book Value
-
EBITDA
83.20
Dividend Yield
0.00 %
Industry
-
Sector
-
Return on Equity
12.91
Debt to Equity
0.75
Forecast For
Actual
Growth Rate
Revenue Growth
56.30 %
Net Income Growth
13.43 %
Cash Flow Change
-
ROE
-3.44 %
ROCE
15.00 %
EBITDA Margin (Avg.)
30.45 %

Yearly Financial Results

Annual Financials
2023
2024
2025
TTM
Revenue
185
206
323
0
Expenses
149
166
239
0
EBITDA
36
41
83
0
Operating Profit %
18 %
19 %
24 %
0 %
Depreciation
2
4
7
0
Interest
4
6
15
0
Profit Before Tax
30
31
44
0
Tax
9
9
20
0
Net Profit
21
22
25
0
EPS in ₹
20.38
21.87
28.63
0.00

Balance Sheet

Balance Sheet
2023
2024
2025
Total Assets
252
339
456
Fixed Assets
23
60
74
Current Assets
176
199
265
Capital Work in Progress
12
19
63
Investments
0
0
0
Other Assets
217
260
319
Total Equity & Liabilities
252
339
456
Current Liabilities
108
140
179
Non Current Liabilities
16
37
86
Total Equity
127
162
190
Reserve & Surplus
126
160
188
Share Capital
2
2
2

Cash Flow

Cash Flow
2023
2024
2025
Net Cash Flow
25
-52
-7
Investing Activities
-26
-45
-59
Operating Activities
25
-24
-1
Financing Activities
26
17
53

Share Holding

% Holding
May 2026
Promoter
67.51 %
FIIs
1.67 %
DIIs
10.14 %
Government
0.00 %
Public / Retail
15.97 %
Others
4.70 %
No of Share Holders
3,497

Technical Indicators

RSI(14)
0.00
ATR(14)
0.00
STOCH(9,6)
0.00
STOCH RSI(14)
0.00
MACD(12,26)
0.00
ADX(14)
0.00
UO(9)
0.00
ROC(12)
0.00
WillR(14)
0.00